Document is current
Any future updates will be listed below
-
Authors
Fleischmann, Roy M. https://orcid.org/0000-0002-6630-1477
Alten, Rieke
Pileckyte, Margarita
Lobello, Kasia
Hua, Steven Y.
Cronenberger, Carol
Alvarez, Daniel
Bock, Amy E.
Sewell, K. Lea
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 21 March 2018
Accepted: 13 July 2018
First Online: 15 August 2018
Ethics approval and consent to participate
: This study was conducted in compliance with the ethical principles of the Declaration of Helsinki and in compliance with all International Conference on Harmonization Good Clinical Practice Guidelines. The study protocol, all amendments, and informed consent documentation were reviewed and approved by the institutional review boards or independent ethics committees or both. In addition, all local regulatory requirements were followed. All patients provided informed consent before undergoing any screening procedures.
: Not applicable.
: RMF has received research grants and consulting fees from Pfizer Inc. and AbbVie. RA has received research grants and honoraria from Pfizer Inc. MP declares that she has no competing interests. SYH was an employee of and held stock holdings or stock options (or both) from Pfizer Inc. at the time of the study. KL, CC, DA, AEB, and KLS are full-time employees of and declare stock holdings or stock options (or both) from Pfizer Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
